Open AccessCLINICAL EFFICIENCY AND ANTI-INFLAMMATORY ACTIVITYOF THERAPY IN CHILDREN WITH PERENNIAL ALLERGICRHINITIS
Author(s) -
В. И. Петров,
N. V. Maljuzhinskaya,
Ivan Shishimorov,
A. V. Razvalyaeva
Publication year - 2010
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja912
Subject(s) - medicine , mometasone furoate , combination therapy , desloratadine , nasal administration , pharmacotherapy , corticosteroid , gastroenterology , dermatology , pharmacology
Background. Intranasal corticosteroids and nonsedating antihistamines are the drug classes most often prescribedto treat allergic rhinitis (AR). Treatment guidelines recommend a combination of these agents for moderate to severe AR. Objective: To compare the efficacy of mometasone furoate (MF) nasal spray plus desloratadine (DL)with that of monotherapy with the individual agents in 6-16 years old patients with perennial AR.Methods. A prospective, randomized, open label, parallel group study of the efficiency of MF nasal spray plus DL and of monotherapy with MF or DL in children with persistent allergic rhinitis aged 6-16 in a 12week periodwas conducted. The efficacy of therapy was evaluated by level of markers of an allergic inflammation, indicatorsof a bronchial hyperresponsiveness and by dynamics of clinical symptoms.Results. Combined therapy (DL+MF) restores balance of cytokines: increase the Тh1 activity and decrease the Т2 activity. Combined therapy found to be effective in the majority of AR patients.Сnclusion. Combined therapy with MF and DL in the treatment of perennial AR in children has clinical advan60